Correlation Between Pfizer and Compania Introductora

Can any of the company-specific risk be diversified away by investing in both Pfizer and Compania Introductora at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Compania Introductora into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Compania Introductora de, you can compare the effects of market volatilities on Pfizer and Compania Introductora and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Compania Introductora. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Compania Introductora.

Diversification Opportunities for Pfizer and Compania Introductora

-0.36

Correlation Coefficient

Pfizer  Compania Introductora

Very good diversification

The 3 months correlation between Pfizer and Compania is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Compania Introductora de in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compania Introductora and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Compania Introductora. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compania Introductora has no effect on the direction of Pfizer i.e., Pfizer and Compania Introductora go up and down completely randomly.

Pair Corralation between Pfizer and Compania Introductora

Assuming the 90 days trading horizon Pfizer Inc is expected to generate 0.43 times more return on investment than Compania Introductora. However, Pfizer Inc is 2.33 times less risky than Compania Introductora. It trades about 0.05 of its potential returns per unit of risk. Compania Introductora de is currently generating about -0.02 per unit of risk. If you would invest  785,000  in Pfizer Inc on December 28, 2024 and sell it today you would earn a total of  28,000  from holding Pfizer Inc or generate 3.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  Compania Introductora de

Pfizer Inc

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Compania Introductora

Risk-Adjusted Performance

Very Weak

Over the last 90 days Compania Introductora de has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Compania Introductora is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Pfizer and Compania Introductora

The main advantage of trading using opposite Pfizer and Compania Introductora positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Compania Introductora can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compania Introductora will offset losses from the drop in Compania Introductora's long position.

The idea behind Pfizer Inc and Compania Introductora de pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.